Physician profile

James P Weiner

Physical Medicine & Rehabilitation · Fort Myers, FL

NPI 1972566339

$1,200.22

in general payments reported to CMS, 2019-2025

23 companies · none reported in 2025

See the full distribution for Physical Medicine & Rehabilitation

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Scilex Pharmaceuticals INC. $226.59 2019-2021
Collegium Pharmaceutical, INC. $169.92 2019-2021
Pacira Therapeutics, INC. $142.80 2019-2021
Allergan, INC. $133.18 2019-2020
Radius Health, INC. $60.62 2021
Ipsen Biopharmaceuticals, INC $56.14 2019
Pfizer INC. $55.72 2019-2021
Abbvie INC. $40.25 2021
Lilly USA, LLC $31.50 2020-2021
Redhill Biopharma INC. $30.84 2020
Assertio Therapeutics, INC. $28.98 2019-2020
Grt US Holding, INC. $28.61 2021
Teva Pharmaceuticals USA, INC. $23.83 2019
Fidia Pharma USA INC. $23.19 2019-2020
Biohaven Pharmaceuticals, INC. $21.04 2021
Show all 23 companies
CompanyGeneral paymentsYearsTop products
Upsher-Smith Laboratories LLC $20.22 2019
Zyla Life Sciences, INC. $18.99 2019
Amgen INC. $17.78 2019
Medtronic USA, INC. $16.41 2020
Biodelivery Sciences International, INC. $15.40 2020
Kaleo, INC. $14.53 2019
Abbott Laboratories $12.97 2021
Stimwave Technologies Incorporated $10.71 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James P Weiner

$1,200.22

in general payments reported 2019-2025

Years
2019-2021
Top company
Scilex Pharmaceuticals INC.

https://glasscript.com/doctor/271079/james-p-weiner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.